Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
1
25%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
Recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

completed125%
recruiting125%
unknown125%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Aromatherapy in Reducing PONV for Total Joint Replacement Patients

NCT07281885
unknownphase_3

Nitrate Use to Obtain Radial Spasm Embarrassment (NURSE - TTS Trial)

NCT04766151
terminatedphase_3

Capsaicin Patches In Knee Osteoarthritis In Obese Patients

NCT03153813
completedphase_4

Mild Cognitive Impairment in Parkinson's Disease

NCT01519271

Clinical Trials (4)

Showing 4 of 4 trials
NCT07281885Not Applicable

Aromatherapy in Reducing PONV for Total Joint Replacement Patients

Recruiting
NCT04766151Phase 3

Nitrate Use to Obtain Radial Spasm Embarrassment (NURSE - TTS Trial)

Unknown
NCT03153813Phase 3

Capsaicin Patches In Knee Osteoarthritis In Obese Patients

Terminated
NCT01519271Phase 4

Mild Cognitive Impairment in Parkinson's Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4